Position paper on the draft bill to improve the supply of medicinal products
In late July, the Federal Ministry of Health (BMG) submitted a draft bill aimed at improving the supply of medicinal products in the statutory health insurance funds (AM-VSG). BIO Deutschland has drafted a position paper focused on this legislation and also made clear at a BMG hearing in August that introducing a turnover ceiling in the first year after approval would hinder the development of innovative therapies.
Funding programmes, competitions and awards
Funding announcements of the Federal Ministry of Education and Research (BMBF) Guidelines for the funding of “Multilateral Cooperation in Computational Neuroscience: …